Zhong Shizhen, the senior academician of Chinese Academy of Engineering, was born in Wuhua County, Guangdong Province in 1925. He is the founder of Chinese clinical anatomy, and the advocate of digital human modeling and digital medicine in China. His academic services involved Honorary President of Chinese Society for Anatomical Sciences, Honorary Director of the Institute of Clinical Anatomy in Southern Medical University, Honorary Director of the Trauma Treatment Research Center of Guangdong Province, lifelong Honorary Chairman of Digital Medicine Branch in Chinese Medical Association, Honorary President of the International Association of Digital Medicine, Honorary Chairman of Additive Manufacturing Association of Guangdong Province, Executive Chairman of the 174th and 208th Xiangshan Science Conference. His academic honors cover six Second Prizes of National S&T Progress Award, Guangdong Province S&T Outstanding Contribution Award, S&T Progress Award by the HO Leung HO Lee Foundation, Founding Achievement Award of Chinese Medical Association Digital Medicine Branch, China Microsurgery Lifetime Achievement Award, YE Jianying Award, and KE Lin Medicine Award. He was elected as a member of the 6th National People's Congress and received honorary titles including "National Excellent Teacher", "Excellent Communist Party Member of the PLA", and "Renowned Science and Technology Teacher of General Logistics Department of the PLA".
Yao Kaitai, the academician of the Chinese Academy of Sciences, is a famous tumor pathophysiologist in China. He is currently a professor and doctoral supervisor of the Cancer Institute of Southern Medical University and a member of the academic committee of the Chinese Academy of Medical Sciences. He has successively served as the director of the Department of the Pathophysiology and the Cancer Research Institute of Xiangya Medical College of Central South University (the former Hunan Medical University), the director of the Key Laboratory of Carcinogenesis of Ministry of Health, and the director of the Cancer Research Institute of Southern Medical University.
As the principal founder of nasopharyngeal carcinoma research in China, Academician Yao Kaitai has been devoted to the research of epidemiology, etiology and pathogenesis, experimental pathology, molecular biology, and molecular genetics of nasopharyngeal carcinoma. For the first time, he has revealed the relationship between nitrosamines and the chemical etiology of nasopharyngeal carcinoma and put forward new insights into the prevention and pathogenesis of nasopharyngeal carcinoma. In addition, he has developed a stable protocol for the culture of human embryonic nasopharyngeal epithelial cells and has successfully induced their malignant transformation by dinitropyrazine. He has established an EBV latent infected human nasopharyngeal carcinoma epithelial cell line for the first time. Furthermore, he has investigated the relationship between EBV and nasopharyngeal carcinoma, the molecular mechanism of pathogenesis, and the susceptibility of nasopharyngeal carcinoma at the molecular level. As the first or corresponding author, he has published more than 300 papers, over 60 of which were published in the SCI-E indexed journals. He has successively won the Second Prize of the State S&T Progress Award, the Third Prize of the State Technological Invention Award, the Second Prize of the Scientific and Technological Progress Award of the Ministry of Health, and the Second Prize of the Scientific and Technological Progress Award of the State Education Commission. He has also received honorary titles such as the Excellent National Teacher, the Young and Middle-Aged Expert with Outstanding Contributions, and the Medical Leading Talent of Guangdong Province.
Hou Fanfan was born in October 1950 in Shanghai, China and received her Medical PhD from Sun Yat-sen University in 1993. She furthered her investigation as a visiting scientist in Harvard Medical School for 3 years. She was elected as academician of Chinese Academy of Sciences in 2009, and academician of The Third World Academy of Sciences in 2012. Currently she serves as an executive committee member of the Kidney Disease Improving Global Outcomes (KDIGO) and the Councilor of the International Society of Nephrology (ISN), chairs ISN North and East Asia Regional Board, and presides the National Clinical Research Center for Kidney Disease, the State Key Laboratory of Organ Failure Research, and Nephrology Department of Nanfang Hospital of Southern Medical University.
Hou Fanfan has made outstanding contributions to prevention and treatment of kidney diseases. She has been the leading principal investigator in several large-scale epidemiological studies which revealed disease burden and risk factors of major kidney diseases in China. Through evidence-based studies, she has developed new strategies for clinical prevention and treatment of chronic kidney diseases, and improved the risk classification by establishing models for predicting the development and prognosis of acute kidney injuries. Through basic research, she has revealed mechanisms underlying renal fibrosis and identified novel targets for intervention. The results of these studies have been confirmed to improve the outcomes of kidney diseases, and advance the clinical research in nephrology. Hou Fanfan has published numerous papers in prestigious, peer-reviewed journals including N Engl J Med, JAMA, Lancet, Nat Med, J Am Soc Nephrol, etc. As the principal investigator, she has won three second prizes of the National S&T Progress Award by the State Council of China and five first prizes of the Provincial/Ministry S&T Progress Award. She has been granted five patents, including one issued by the US Patent Office. She received many rewards, including Science and Technology Progress Award by the HO Leung HO Lee Foundation, Science and Technology Outstanding Contribution Award of Guangdong Province, and Chinese Doctor Award. She is also honored as National March-eighth Red-Banner Pacesetter, and National Outstanding Scientific and Technological Professional.
Gao Tianming, an academician of the Chinese Academy of Engineering, is a professor of neurobiology at SMU. He chairs the Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brian-Inspired Intelligence, and Guangdong Key Laboratory of Psychiatric Disorders. He serves as vice president of Chinese Neuroscience Society, and deputy managing editor of Pharmacol Res and Neurosci Bull. He has been working on neuroprotection and anti-depression research. The research projects he hosted include one innovation team project under the Ministry of Education of China, seven key projects of the National Natural Science Foundation of China, and one 973 Project (National Key Basic Research Program). As a corresponding author, he has his research harvests published in famous international periodicals and journals, such as Nat Med, Nat Neurosci, Neuron, Nat Commun, Biol Psychiat, JCI and PNAS. His honors involve two second prizes of National Natural Science Award, three first prizes of provincial or ministerial Science and Technology.
